Personalized antiplatelet therapy in acute coronary syndromes: a dead-end street or a future scenario?

Author： Marcucci Rossella Giusti Betti Abbate Rosanna

ISSN： 1755-5302

Source： Interventional Cardiology, Vol.5, Iss.6, 2013-12, pp. : 601-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prasugrel: A Novel Antiplatelet Therapy for Acute Coronary Syndromes

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 3, 2009-11 ,pp. : 192-202

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Antiplatelet Therapy in Acute Coronary Syndromes: What is New in the Pipeline?

Current Vascular Pharmacology, Vol. 10, Iss. 5, 2012-09 ,pp. : 606-618

Bentham Science Publishers

Access to resources Recommend Favorite

Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review

Current Cardiology Reviews, Vol. 13, Iss. 4, 2017-10 ,pp. : 325-333

Bentham Science Publishers

Access to resources Recommend Favorite

Anticoagulant therapy in acute coronary syndromes

By Bates Eric R

Future Cardiology, Vol. 3, Iss. 3, 2007-05 ,pp. : 301-308

Future Medicine

Access to resources Recommend Favorite

Current Status of Antiplatelet Therapy in Acute Coronary Syndrome

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 13, Iss. 1, 2015-01 ,pp. : 40-49

Bentham Science Publishers

Access to resources Recommend Favorite